Non-Cancerous Skin Diseases Therapeutics Market 2024-2028
Incremental Growth2024-2028 (US$bn)
$ 25.22
2024 Year-over-Year Growth
8.95%
CAGR (2024-2028)
9.88%
Report Coverage
Global
Non-Cancerous Skin Diseases Therapeutics Market Segmentation
Market Segmentation & Scope
Market Segment by Geographic Landscape
36%
of the growth will originate
from North America
Global Market Size 2018 - 2028 (US$ Bn)
Market is segmented by Therapy Area into Psoriasis, Eczema, Acne vulgaris, Others
The Psoriasis is expected to be largest growing segment during 2024-2028
Largest Segment - Psoriasis
US$ 65.13 Bn
Non-Cancerous Skin Diseases Therapeutics Market by Therapy Area into Psoriasis; 2018-2028 (US$ Bn)
Psoriasis Market Revenue and Forecast 2018-2028 (US$ Bn)Psoriasis
- Psoriasis Market Size and Forecast 2018 to 2028 (US$ Bn)
Non-Cancerous Skin Diseases Therapeutics Market by Therapy Area into Eczema; 2018-2028 (US$ Bn)
Eczema Market Revenue and Forecast 2018-2028 (US$ Bn)Eczema
- Eczema Market Size and Forecast 2018 to 2028 (US$ Bn)
Non-Cancerous Skin Diseases Therapeutics Market by Therapy Area into Acne vulgaris; 2018-2028 (US$ Bn)
Acne vulgaris Market Revenue and Forecast 2018-2028 (US$ Bn)Acne vulgaris
- Acne vulgaris Market Size and Forecast 2018 to 2028 (US$ Bn)
Non-Cancerous Skin Diseases Therapeutics Market by Therapy Area into Others; 2018-2028 (US$ Bn)
Others Market Revenue and Forecast 2018-2028 (US$ Bn)Others
- Others Market Size and Forecast 2018 to 2028 (US$ Bn)
Market is segmented by Route Of Administration into Injectable, Oral, Topical
The Injectable is expected to be largest growing segment during 2024-2028
Largest Segment - Injectable
US$ 79.80 Bn
Non-Cancerous Skin Diseases Therapeutics Market Size by Segmentation, by Route Of Administration (US$ Bn)
| Route Of Administration | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Injectable | 14.39 | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX |
| Oral | XX | 11.09 | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX |
| Topical | XX | XX | 7.04 | XX | XX | XX | XX | XX | XX | XX | XX | XX |
Non-Cancerous Skin Diseases Therapeutics Market by Route Of Administration into Injectable; 2018-2028 (US$ Bn)
Injectable Market Revenue and Forecast 2018-2028 (US$ Bn)Injectable
- Injectable Market Size and Forecast 2018 to 2028 (US$ Bn)
Non-Cancerous Skin Diseases Therapeutics Market by Route Of Administration into Oral; 2018-2028 (US$ Bn)
Oral Market Revenue and Forecast 2018-2028 (US$ Bn)Oral
- Oral Market Size and Forecast 2018 to 2028 (US$ Bn)
Non-Cancerous Skin Diseases Therapeutics Market by Route Of Administration into Topical; 2018-2028 (US$ Bn)
Topical Market Revenue and Forecast 2018-2028 (US$ Bn)Topical
- Topical Market Size and Forecast 2018 to 2028 (US$ Bn)
Market is segmented by Geography into North America, Europe, Asia, ROW
The North America is estimated to contribute 36% to the growth of global market during the forecast period 2024-2028.
Largest Segment - North America
36%
Regional share of different regions, including North America, Europe, Asia, Rest of World (ROW)
| Region | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 10.78 | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX |
| Europe | XX | 10.39 | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX |
| Asia | XX | XX | 7.98 | XX | XX | XX | XX | XX | XX | XX | XX | XX |
| ROW | XX | XX | XX | 3.84 | 4.11 | XX | XX | XX | XX | XX | XX | XX |
Non-Cancerous Skin Diseases Therapeutics Market Size by Geography into North America; 2018-2028 (US$ Bn)
North America Market Revenue and Forecast 2018-2028 (US$ Bn)Non-Cancerous Skin Diseases Therapeutics Market Size by Country into Canada; 2018-2028 (US$ Bn)
Canada Market Revenue and Forecast 2018-2028 (US$ Bn)Non-Cancerous Skin Diseases Therapeutics Market Size by Country into US; 2018-2028 (US$ Bn)
US Market Revenue and Forecast 2018-2028 (US$ Bn)Non-Cancerous Skin Diseases Therapeutics Market Size by Geography into Europe; 2018-2028 (US$ Bn)
Europe Market Revenue and Forecast 2018-2028 (US$ Bn)Non-Cancerous Skin Diseases Therapeutics Market Size by Country into Germany; 2018-2028 (US$ Bn)
Germany Market Revenue and Forecast 2018-2028 (US$ Bn)Non-Cancerous Skin Diseases Therapeutics Market Size by Country into UK; 2018-2028 (US$ Bn)
UK Market Revenue and Forecast 2018-2028 (US$ Bn)Non-Cancerous Skin Diseases Therapeutics Market Size by Geography into Asia; 2018-2028 (US$ Bn)
Asia Market Revenue and Forecast 2018-2028 (US$ Bn)Non-Cancerous Skin Diseases Therapeutics Market Size by Country into China; 2018-2028 (US$ Bn)
China Market Revenue and Forecast 2018-2028 (US$ Bn)Non-Cancerous Skin Diseases Therapeutics Market Size by Geography into ROW; 2018-2028 (US$ Bn)
ROW Market Revenue and Forecast 2018-2028 (US$ Bn)Major Companies
Market Companies
| Name | Profile | Employees | Headquarters | Website | |
|---|---|---|---|---|---|
| AbbVie Inc. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| Amgen Inc. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| AstraZeneca Plc | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| Bayer AG | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| Bristol Myers Squibb Co. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| Eli Lilly and Co. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| F. Hoffmann La Roche Ltd. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| Galderma SA | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| GlaxoSmithKline Plc | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| Incyte Corp. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| LEO Pharma AS | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| Merck KGaA | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| Novartis AG | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| Pfizer Inc. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| Regeneron Pharmaceuticals Inc. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| Sanofi SA | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| Sun Pharmaceutical Industries Ltd. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| UCB SA | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| Viatris Inc. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| XBiotech Inc. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com |
Non-Cancerous Skin Diseases Therapeutics Market Scope
- By Therapy Area
- Introduction / Key Findings
- Historical Market Size Value (US$ billion) Analysis By Therapy Area, 2018 to 2022
- Current and Future Market Size Value (US$ billion) Analysis and Forecast By Therapy Area, 2024 to 2028
- Y-o-Y Growth Trend Analysis By Therapy Area, 2018 to 2022
- Absolute $ Opportunity Analysis By Therapy Area, 2024 to 2028
- By Route Of Administration
- Introduction / Key Findings
- Historical Market Size Value (US$ billion) Analysis By Route Of Administration, 2018 to 2022
- Current and Future Market Size Value (US$ billion) Analysis and Forecast By Route Of Administration, 2024 to 2028
- Y-o-Y Growth Trend Analysis By Route Of Administration, 2018 to 2022
- Absolute $ Opportunity Analysis By Route Of Administration, 2024 to 2028
- By Region
- Introduction / Key Findings
- Historical Market Size Value (US$ billion) Analysis By Region, 2018 to 2022
- Current and Future Market Size Value (US$ billion) Analysis and Forecast By Region, 2024 to 2028
- North America Market Analysis 2018 to 2022 and Forecast 2024 to 2028, By Country
- Historical Market Size Value (US$ billion) Trend Analysis By Market, 2018 to 2022
- Market Size Value (US$ billion) Forecast By Market, 2024 to 2028
- By Country
- By Therapy Area
- By Route Of Administration
- Europe Market Analysis 2018 to 2022 and Forecast 2024 to 2028, By Country
- Historical Market Size Value (US$ billion) Trend Analysis By Market, 2018 to 2022
- Market Size Value (US$ billion) Forecast By Market, 2024 to 2028
- By Country
- By Therapy Area
- By Route Of Administration
- Asia Market Analysis 2018 to 2022 and Forecast 2024 to 2028, By Country
- Historical Market Size Value (US$ billion) Trend Analysis By Market, 2018 to 2022
- Market Size Value (US$ billion) Forecast By Market, 2024 to 2028
- By Country
- By Therapy Area
- By Route Of Administration
- Rest of World (ROW) Market Analysis 2018 to 2022 and Forecast 2024 to 2028, By Country
- Historical Market Size Value (US$ billion) Trend Analysis By Market, 2018 to 2022
- Market Size Value (US$ billion) Forecast By Market, 2024 to 2028
- By Therapy Area
- By Route Of Administration
Major Companies
Market companies
| Name | Profile | Employees | Headquarters | Website | |
|---|---|---|---|---|---|
| AbbVie Inc. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| Amgen Inc. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| AstraZeneca Plc | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| Bayer AG | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| Bristol Myers Squibb Co. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| Eli Lilly and Co. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| F. Hoffmann La Roche Ltd. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| Galderma SA | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| GlaxoSmithKline Plc | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| Incyte Corp. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| LEO Pharma AS | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| Merck KGaA | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| Novartis AG | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| Pfizer Inc. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| Regeneron Pharmaceuticals Inc. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| Sanofi SA | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| Sun Pharmaceutical Industries Ltd. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| UCB SA | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| Viatris Inc. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
| XBiotech Inc. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com |
Subscribe to World-Class Market Intelligence
Basic Plan
Experience the best of reports & insights
